Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's Disease

BACKGROUND: Inhibiting catechol‐O‐methyltransferase extends the plasma half‐life of levodopa, potentially allowing physicians to optimize the levodopa regimen in patients with Parkinson's disease (PD) experiencing motor fluctuations. OBJECTIVES: To evaluate the effects of once‐daily opicapone o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Joaquim J., Poewe, Werner, Rascol, Olivier, Stocchi, Fabrizio, Antonini, Angelo, Moreira, Joana, Guimarães, Bruno, Rocha, José‐Francisco, Soares‐da‐Silva, Patrício
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804871/
https://www.ncbi.nlm.nih.gov/pubmed/36054562
http://dx.doi.org/10.1002/mds.29193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804871/
https://www.ncbi.nlm.nih.gov/pubmed/36054562
http://dx.doi.org/10.1002/mds.29193

Ejemplares similares